Literature DB >> 22587519

(Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies.

M V Ramana Reddy1, Balaiah Akula, Stephen C Cosenza, Clement M Lee, Muralidhar R Mallireddigari, Venkat R Pallela, D R C Venkata Subbaiah, Andrew Udofa, E Premkumar Reddy.   

Abstract

Tubulin, the major structural component of microtubules, is a target for the development of anticancer agents. A series of (Z)-1-aryl-3-arylamino-2-propen-1-one (10) were synthesized and evaluated for antiproliferative activity in cell-based assay. The most active compound (Z)-1-(2-bromo-3,4,5-trimethoxyphenyl)-3-(3-hydroxy-4-methoxyphenylamino)prop-2-en-1-one (10ae) was tested in 20 tumor cell lines including multidrug resistant phenotype and was found to induce apoptosis in all these cell lines with similar GI(50) values. Flow cytometry studies showed that 10ae arrested the cells in G2/M phase of cell cycle. In addition to G2/M block, these compounds caused microtubule stabilization like paclitaxel and induced apoptosis via activation of the caspase family. The observations made in this investigation demonstrate that (Z)-1-Aryl-3-arylamino-2-propen-1-one (10) represents a new class of microtubule-stabilizing agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22587519      PMCID: PMC3375384          DOI: 10.1021/jm300176j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  50 in total

1.  One-pot synthesis of benzo[b]furan and indole inhibitors of tubulin polymerization.

Authors:  Bernard L Flynn; Ernest Hamel; M Katherine Jung
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

Review 2.  Phosphorylation of serine 10 in histone H3, what for?

Authors:  Claude Prigent; Stefan Dimitrov
Journal:  J Cell Sci       Date:  2003-09-15       Impact factor: 5.285

Review 3.  Mechanism of action of antitumor drugs that interact with microtubules and tubulin.

Authors:  M A Jordan
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-01

4.  Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents.

Authors:  S Mahboobi; H Pongratz; H Hufsky; J Hockemeyer; M Frieser; A Lyssenko; D H Paper; J Bürgermeister; F D Böhmer; H H Fiebig; A M Burger; S Baasner; T Beckers
Journal:  J Med Chem       Date:  2001-12-20       Impact factor: 7.446

5.  New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.

Authors:  B G Szczepankiewicz; G Liu; H S Jae; A S Tasker; I W Gunawardana; T W von Geldern; S L Gwaltney; J R Wu-Wong; L Gehrke; W J Chiou; R B Credo; J D Alder; M A Nukkala; N A Zielinski; K Jarvis; K W Mollison; D J Frost; J L Bauch; Y H Hui; A K Claiborne; Q Li; S H Rosenberg
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

6.  Promotion of microtubule assembly in vitro by taxol.

Authors:  P B Schiff; J Fant; S B Horwitz
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

7.  Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.

Authors:  Jing-Ping Liou; Yi-Ling Chang; Fu-Ming Kuo; Chun-Wei Chang; Huan-Yi Tseng; Chiung-Chiu Wang; Yung-Ning Yang; Jang-Yang Chang; Shiow-Ju Lee; Hsing-Pang Hsieh
Journal:  J Med Chem       Date:  2004-08-12       Impact factor: 7.446

8.  Total synthesis of (+)-isoschizandrin utilizing a samarium(II) iodide-promoted 8-endo ketyl-olefin cyclization.

Authors:  Gary A Molander; Kelly M George; Lauren G Monovich
Journal:  J Org Chem       Date:  2003-12-12       Impact factor: 4.354

Review 9.  Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update.

Authors:  C Soldani; A Ivana Scovassi
Journal:  Apoptosis       Date:  2002-08       Impact factor: 4.677

Review 10.  Combretastatin A-4 analogues as antimitotic antitumor agents.

Authors:  Nguyen-Hai Nam
Journal:  Curr Med Chem       Date:  2003-09       Impact factor: 4.530

View more
  6 in total

1.  Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor.

Authors:  Jia Liu; Dongwei Xue; Xingwang Zhu; Liu Yu; Minghuan Mao; Yili Liu
Journal:  Invest New Drugs       Date:  2019-06-10       Impact factor: 3.850

Review 2.  Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease.

Authors:  Kurt R Brunden; John Q Trojanowski; Amos B Smith; Virginia M-Y Lee; Carlo Ballatore
Journal:  Bioorg Med Chem       Date:  2013-12-30       Impact factor: 3.641

3.  Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site.

Authors:  Xin Zhai; Xiaoqiang Wang; Jiao Wang; Jin Liu; Daiying Zuo; Nan Jiang; Tianfang Zeng; Xiuxiu Yang; Tongfei Jing; Ping Gong
Journal:  Sci Rep       Date:  2017-02-27       Impact factor: 4.379

4.  WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects.

Authors:  Fang Guan; Rui Ding; Qi Zhang; Wei Chen; Feifei Li; Long Long; Wei Li; Linna Li; Dexuan Yang; Lan Xie; Shoujun Yuan; Lili Wang
Journal:  Oncotarget       Date:  2017-05-09

5.  Synthesis, Biological Evaluation, and Molecular Modeling Studies of 1-Aryl-1H-pyrazole-Fused Curcumin Analogues as Anticancer Agents.

Authors:  Nam Q H Doan; Ngan T K Nguyen; Vu B Duong; Ha T T Nguyen; Long B Vong; Diem N Duong; Nguyet-Thu T Nguyen; Tuyen L T Nguyen; Tuoi T H Do; Tuyen N Truong
Journal:  ACS Omega       Date:  2022-09-16

Review 6.  The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress.

Authors:  Mugahed Abdullah Hasan Albahde; Bulat Abdrakhimov; Guo-Qi Li; Xiaohu Zhou; Dongkai Zhou; Hao Xu; Huixiao Qian; Weilin Wang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.